Patents by Inventor Wlodek Mandecki

Wlodek Mandecki has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9418321
    Abstract: Provided herein, among other things, is an assembly consisting of a tissue cassette or slide and an affixed transponder.
    Type: Grant
    Filed: September 22, 2011
    Date of Patent: August 16, 2016
    Assignee: Pharmaseq, Inc.
    Inventors: Maryann Gruda, Wlodek Mandecki, Ziye Qian
  • Publication number: 20160175801
    Abstract: Provided is a method of synthesis comprising: (I) providing separate reaction sequences to TABs; (II) utilizing reaction vessels configured to react a separate combinatorial building block with a moiety on a surface of a TAB; and (III) operating one or more TAB sorters comprising a TAB reader, a sorting tree comprising valves or switches and sorting nodes, and a monitor configured to detect TAB location, wherein the operating comprises serially conducting: (a) reacting distinct combinatorial building blocks in the reaction chambers with surfaces of TABs distributed in the reaction chambers; (b) operating a controller to operate the TAB sorters to segregate the TABs to allocations appropriate for the next assigned reaction, the operating including recycling TABs with ambiguous identity back through the sorter; and (c) repeating steps (a) and (b) as needed to complete 30% or more of the assigned sequences.
    Type: Application
    Filed: December 17, 2015
    Publication date: June 23, 2016
    Inventors: Wlodek Mandecki, Efrain "Frank" Rodriguez, Ziye "Jay" Qian
  • Patent number: 9313558
    Abstract: Provided herein, among other things, is an assembly comprising a pin or a piece of jewelry and a transponder affixed thereto. The transponder can be a very small, light-triggered transponder (“MTP”).
    Type: Grant
    Filed: September 22, 2011
    Date of Patent: April 12, 2016
    Assignee: Pharmaseq Inc.
    Inventors: Wlodek Mandecki, Ziye Qian, Richard Morris, Garry Thomas Jolley-Rogers, David Keith Yeates, Philip John Suter, James Reginald Croft, Edith Margaret Cawsey, Jeffrey Michael Webb
  • Publication number: 20150118678
    Abstract: The present invention provides a novel assay that allows high-throughput screening of chemical compounds for the inhibition of binding between EF-Tu and tRNA.
    Type: Application
    Filed: October 31, 2014
    Publication date: April 30, 2015
    Inventors: Wlodek Mandecki, Emanuel Goldman, Maxim Chudaev
  • Patent number: 8785352
    Abstract: Provided, among other things, is a multiplex assay comprising: conducting a fluorescence-developing assay on microtabs having at least one surface that shows plasmonic enhancement, wherein a plurality of the microtabs have unique probes affixed to their plasmonically enhanced surfaces; and measuring the fluorescence associated with the substrates and identifying the correlated probe by for the microtab. The microtabs can be, for example, MTPs that send a unique identifier, and the correlated probe can be identified by querying the MTPs for their identifier.
    Type: Grant
    Filed: April 29, 2011
    Date of Patent: July 22, 2014
    Assignee: Pharmaseq, Inc.
    Inventors: Wlodek Mandecki, Ji Li, Zhuying Wang
  • Publication number: 20140106470
    Abstract: Provided among other things is an analyzer for use with tabs placed in a vessel comprising: a stochastic sampling device adapted to receive the vessel; a light beam source adapted to enter the moving vessel and selectively illuminate tabs; an analytical signal receiver adapted to receive a signal indicative of an analytical process occurring on the surface of the tab as the tab is selectively illuminated; a tab ID receiver adapted to collect ID data from the tabs in coordination with their selective illumination; and a controller for associating identified tabs with analytical signals.
    Type: Application
    Filed: October 15, 2013
    Publication date: April 17, 2014
    Applicant: PharmaSeq, Inc.
    Inventors: Wesley Kopacka, Wlodek Mandecki, Richard Morris
  • Publication number: 20130123118
    Abstract: Provided, among other things, is a multiplex assay comprising: conducting a fluorescence-developing assay on microtabs having at least one surface that shows plasmonic enhancement, wherein a plurality of the microtabs have unique probes affixed to their plasmonically enhanced surfaces; and measuring the fluorescence associated with the substrates and identifying the correlated probe by for the microtab. The microtabs can be, for example, MTPs that send a unique identifier, and the correlated probe can be identified by querying the MTPs for their identifier.
    Type: Application
    Filed: April 29, 2011
    Publication date: May 16, 2013
    Applicant: PharmaSeq, Inc.
    Inventors: Wlodek Mandecki, Ji Li, Zhuying Wang
  • Patent number: 8353917
    Abstract: Provided are methods and apparatus including an injector system adapted for injecting a microchip comprising: an inserter comprising a rod or tube having a proximal and distal end and having a point at the distal end that defines a skin-piercing side of the inserter; a means for engaging the microchip near the distal end of the inserter, but removed in the proximal direction from the distal tip of the inserter, which means prevents rotation of an engaged microchip in two or three axes of rotation; and means for releasing the microchip from the inserter once the inserter has been inserted into a perforatable substrate.
    Type: Grant
    Filed: September 23, 2010
    Date of Patent: January 15, 2013
    Assignee: PharmaSeq, Inc.
    Inventors: Wlodek Mandecki, Hanan Davidowitz, Maryann Gruda, Edward Kuspiel, Joseph Nolfo, Ziye (Jay) Qian, Gary H. Reitnauer
  • Patent number: 8323886
    Abstract: Provided is an assay method for acquiring sequence information about a single ribonucleic acid, the method comprising: (A) contacting components including a ribosomal particle comprising a ribosome and the ribonucleic acid with a complex comprising moieties that are aa1-tRNA, EF-Tu and GTP or a functional analog, wherein at least one said moiety is labeled with a fluorescent molecule, wherein aa1-tRNA is a tRNA for first amino acid aa1; (B) providing, in conjunction with the contacted components, a ribosomal translation component mixture; (C) generating a fluorescent signal from a labeled moiety in correlation with the incorporation of aa1 into protein and the labeled moiety is thereby separated from the complex; and (D) detecting the signal to provide sequence information about the ribonucleic acid.
    Type: Grant
    Filed: June 18, 2004
    Date of Patent: December 4, 2012
    Inventor: Wlodek Mandecki
  • Publication number: 20110077659
    Abstract: Provided are methods and apparatus including an injector system adapted for injecting a microchip comprising: an inserter comprising a rod or tube having a proximal and distal end and having a point at the distal end that defines a skin-piercing side of the inserter; a means for engaging the microchip near the distal end of the inserter, but removed in the proximal direction from the distal tip of the inserter, which means prevents rotation of an engaged microchip in two or three axes of rotation; and means for releasing the microchip from the inserter once the inserter has been inserted into a perforatable substrate.
    Type: Application
    Filed: September 23, 2010
    Publication date: March 31, 2011
    Applicant: Pharmaseq Inc.
    Inventors: Wlodek Mandecki, Hanan Davidowitz, Maryann Gruda, Edward Kuspiel, Joseph Nolfo, Ziye "Jay" Qian, Gary H. Reitnauer
  • Publication number: 20060252697
    Abstract: The present invention provides peptides that bind to the active site of the growth hormone receptor. The present invention also provides methods of using these peptides to identify small organic molecules, which are novel agonists or antagonists of the growth hormone receptor. In addition, the present invention provides kits and therapeutic compositions comprising the peptides that bind to growth hormone receptor.
    Type: Application
    Filed: April 4, 2002
    Publication date: November 9, 2006
    Inventors: Arthur Blume, Renee Brissette, Juan Carcamo, Wlodek Mandecki, Pauline Tang
  • Publication number: 20050282173
    Abstract: An assay method for acquiring sequence information about a single nucleic acid molecule is provided. Probes and kits are also provided for practicing the method of the invention.
    Type: Application
    Filed: June 18, 2004
    Publication date: December 22, 2005
    Inventor: Wlodek Mandecki
  • Patent number: 6686158
    Abstract: Disclosed are materials and methods for detecting biomolecules in samples employing transponders associated with the bead(s) used as the solid phase in the assay, and information pertinent to the assay is encoded on the transponders memory elements. A dedicated read/write device is used remotely to encode or remotely to read the information. The invention can be used in direct or competitive ELISA-type assays, or in multiplex assays for the simultaneous assay of several analytes.
    Type: Grant
    Filed: July 17, 2001
    Date of Patent: February 3, 2004
    Assignee: Pharma Seg, Inc.
    Inventor: Wlodek Mandecki
  • Publication number: 20030143619
    Abstract: A method is described for determining the sequence of nucleic acids. The method employs small solid phase particles having transponders, with a primary layer of an oligonucleotide of known sequence attached to the outer surface of the particle. A read/write scanner device is used to encode and decode data on the transponder. The stored data includes the sequence of the oligonucleotide immobilized on the transponder. The sequence of sample nucleic acids is determined by detecting annealing to an oligonucleotide bound to a particle, followed by decoding the transponder to determine the sequence of the oligonucleotide.
    Type: Application
    Filed: January 27, 2003
    Publication date: July 31, 2003
    Applicant: Pharmaseq, Inc.
    Inventor: Wlodek Mandecki
  • Publication number: 20030062988
    Abstract: An identification system having a light source, an identifiable object and a receiver. The identifiable object having one or more photo-activated microtransponders operatively connected to an article. The photo-activated microtransponders are operative to transmit one or more output signals to the receiver in response to one or more light signals from the light source.
    Type: Application
    Filed: October 2, 2001
    Publication date: April 3, 2003
    Inventors: Wlodek Mandecki, Michael Pappas, Hananel H. Davidowitz
  • Publication number: 20030063351
    Abstract: A microtransponder sensing system having a light source and receiver device. The light source provides a light signal that is positioned with the receiver device and in relation to a microtransponder. The microtransponder transmits an output signal in response to the light signal. The receiver device receives the output signal.
    Type: Application
    Filed: October 2, 2001
    Publication date: April 3, 2003
    Inventors: Wlodek Mandecki, Hananel H. Davidowitz, Vladimir R. Furman
  • Publication number: 20020143144
    Abstract: Materials and methods are disclosed for identifying chemical compounds having desired binding properties towards a binding partner of pharmaceutical interest. The method employs transponders associated with the solid phase material used in the assay and a scanner to encode and decode data stored electronically on the transponder. The data stored on the transponder identifies the monomeric building blocks added during the synthesis. The structural identification of synthesized compounds bound to the solid phase is done by decoding the transponder.
    Type: Application
    Filed: March 26, 2002
    Publication date: October 3, 2002
    Applicant: Pharmaseq, Inc.
    Inventor: Wlodek Mandecki
  • Patent number: 6440700
    Abstract: Disclosed are materials and methods for practicing combinatorial protein synthesis based on ribosomal frameshifting. The genes, encoding the proteins to be synthesized, are constructed by assembly of several double-stranded DNA fragments and are cloned into bacteria. The genes include interspersed frameshifting sequences. Proteins are made in the cell by translating nucleotide sequences in a combinatorial mode. The invention can be used for the selection of new, modified or improved proteins.
    Type: Grant
    Filed: August 16, 2000
    Date of Patent: August 27, 2002
    Inventor: Wlodek Mandecki
  • Patent number: 6387623
    Abstract: Materials and methods are disclosed for identifying chemical compounds having desired binding properties towards a binding partner of pharmaceutical interest. The method employs transponders associated with the solid phase material used in the assay and a scanner to encode and decode data stored electronically on the transponder. The data stored on the transponder identifies the monomeric building blocks added during the synthesis. The structural identification of synthesized compounds bound to the solid phase is done by decoding the transponder.
    Type: Grant
    Filed: March 29, 2000
    Date of Patent: May 14, 2002
    Assignee: Pharmaseq
    Inventor: Wlodek Mandecki
  • Patent number: 6376187
    Abstract: Disclosed are materials and methods for detecting biomolecules in samples employing transponders associated with the bead(s) used as the solid phase in the assay, and information pertinent to the assay is encoded on the transponders memory elements. A dedicated read/write device is used remotely to encode or remotely to read the information. The invention can be used in direct or competitive ELISA-type assays, or in multiplex assays for the simultaneous assay of several analytes.
    Type: Grant
    Filed: July 11, 2000
    Date of Patent: April 23, 2002
    Assignee: Pharmaseq, Inc.
    Inventor: Wlodek Mandecki